Literature DB >> 82605

Immunological dissection of human Ia molecules.

R Tosi, N Tanigaki, D Centis, G B Ferrara, D Pressman.   

Abstract

The immunochemical analysis of Daudi Ia molecules by a variety of alloantisera led to the recognition of at least three molecular species carrying different antigenic determinants: DRw6, DC-1, and DC-2. Genetic as well as structural evidence indicates that DRw6 and DC-1 molecules are controlled by separate, HLA-linked loci, rather than by alleles at the same locus. The alloantigenic determinants appear to be expressed on the small Ia subunit. DC-1 and DC-2 determinants discussed had not been defined by serological analysis at the population level, but were demonstrated to be present by immunochemical analysis at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82605      PMCID: PMC2185093          DOI: 10.1084/jem.148.6.1592

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  An evaluation of the ethidium bromide microcytotoxicity test.

Authors:  C Darke; E Gay
Journal:  J Immunol Methods       Date:  1974-03       Impact factor: 2.303

2.  Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines.

Authors:  K Nakamuro; N Tanigaki; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

3.  The papain susceptibility of IgG myeloma proteins of different heavy chain subclasses.

Authors:  J Gergely; H H Fudenberg; E van Loghem
Journal:  Immunochemistry       Date:  1970-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  "Silent" alleles at the HLA-C locus.

Authors:  G Ferrara; R Tosi; A Longo; A Castellani; C Viviani; G Carminati
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

6.  Genetics and serology of HL-A-linked human Ia antigens.

Authors:  C J Barnstable; E A Jones; W F Bodmer; J G Bodmer; B Arce-Gomez; D Snary; M J Crumpton
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

7.  Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.

Authors:  K Nakamuro; N Tanigaki
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

8.  Independent expression of the two HL-A antigen polypeptide chains.

Authors:  L Ostberg; L Rask; K Nilsson; P A Peterson
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  A safe blood transfusion procedure for immunization against major histocompatibility complex determinants in man.

Authors:  G B Ferrara; R Tosi; A Longo; A Castellani; C Viviani; G Carminati
Journal:  Transplantation       Date:  1978-09       Impact factor: 4.939

10.  Cellular distrubtion, purification, and molecular nature of human Ia antigens.

Authors:  D Snary; C J Barnstable; W F Bodmer; P N Goodfellow; M J Crumpton
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

View more
  70 in total

1.  Analysis of the DR beta chains from two DRw6 cell lines (WT46 and WT52): recombination in vivo may have generated new haplotypes.

Authors:  P J Knudsen; J McLean; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.

Authors:  R Sorrentino; J Lillie; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5).

Authors:  P Loiseau; P Lehn; F Dautry; V Lepage; J Colombani; D Cohen; J Dausset; L Degos
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes.

Authors:  R Tosi; M Vela; D Adorno; A Longo; F Papola; D Maccarone; D Centis; N Tanigaki; M P Raponi; A Candela
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

5.  Characterization of an HLA DR beta pseudogene.

Authors:  D Larhammar; B Servenius; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features.

Authors:  L Lauriola; P Musiani; A Carbone; M Bartolini; P Cianciulli; M Piantelli
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

7.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.

Authors:  D A Shackelford; D L Mann; J J van Rood; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

Authors:  F Ameglio; M R Capobianchi; A Dolei; R Tosi
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.